
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Jun 23
Feb 23
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read MoreOntosightⓇ is a discovery platform that leverages proprietary artificial intelligence technologies to generate continuous insights for life sciences. OntosightⓇ Influence is a module of the platform that enables real-time discovery and network analysis of knowledgeable specialists, key opinion leaders (KOLs), and influencers across the entire drug discovery and development value chain, from preclinical to post-launch support.
The AI-based platform automatically identifies top and emerging KOLs based on our integrated and continuously updated data ocean consisting of millions of documents from varied asset classes such as publications, congresses, clinical trials, societies, HTAs, advocacy groups, and many more, to ensure the latest and relevant information.
OntosightⓇ Influence has over 20 million profiles for top and emerging KOLs and influencers including therapeutic area expert (TAEs) and digital opinion leaders (DOLs). The module covers the life science data ocean of Innoplexus to identify influential scientific specialists from upto 95% of world wide web, including sources such as 35M+ publications, 580K+ clinical trial, 3M+ congresses, 35K+ treatment guidelines etc.
Pharmaceutical companies can leverage this module to accelerate discovery of key opinion leaders and influencers for their support in different scientific and commercial activities. Data is updated continuously to enable high accuracy of information driving informed business decisions. The module is highly customizable on logic and scoring to support multiple use cases. Interactive infographics, visualizations, and power-maps enable exploration of networks for chosen therapeutic area. Get up-to-date live update notifications for your favourite KOLs and influencers.
The module can be leveraged for multiple use cases across drug development life cycle.
OntosightⓇ OntosightⓇ Influence uses proprietary algorithms to score TAEs on the basis of any resource category. It features a score equalizer which empowers the user to score the KOLs based on their specific use case and enables customizable weightage for different asset classes such as publications, congresses, clinical trials, guidelines, regulatory bodies, HTA, societies, advocacy or top hospital.
The tool uses proprietary algorithms to score TAEs on the basis of any resource category. The asset classes are scored primarily on 3 parameters – Recency, Quantity and Quality. The KOLs can be further filtered by geography, body names, committee names, speciality, biomarkers, etc.Influence features a score equalizer which empowers the user to score the TAEs / KOLs based on their specific use case. The score equalizer enables customizable weightage for different asset classes such as publications, congresses, clinical trials, guidelines, regulatory bodies, HTA, societies, advocacy or top hospital.
OntosightⓇ Influence allows to deep-dive into TAE / KOL profiles.
The ‘Research Activity’ section which summarizes TAE’s / KOL’s contribution trends for publications, clinical trials, congresses etc. over the time of 5, 10, or 20 years. It also allows to view the overall research interest, such as gene, drug, disease in the form of a word cloud. One can view activity of interest using different resources and details to the original source of the document.
The ‘Network’ tab allows to view connections between chosen KOL and other TAEs /KOLs across the globe. These can be filtered using country.
Moreover, KOLs can be bookmarked. Notifications are generated for new research activity related to the chosen KOLs.
OntosightⓇ Influence is a subscription-based platform. Feel free to contact Innoplexus directly to set up a demo and quote. To know more, click here.
The cost of developing a new drug roughly doubles every nine years (inflation-adjusted) aka Eroom’s law.As the volume of data…
There was a time when science depended on manual efforts by scientists and researchers. Then, came an avalanche of data…
Collaboration with key opinion leaders and influencers becomes crucial at various stages of the drug development chain. When a pharmaceutical…
Data are not the new gold – but the ability to put them together in a relevant and analyzable way…
Artificial intelligence, or AI, is gaining more attention in the pharma space these days. At one time evoking images from…
Artificial intelligence (AI) is transforming the pharmaceutical industry with extraordinary innovations that are automating processes at every stage of drug…
There is a lot of buzz these days about how artificial intelligence (AI) is going to disrupt the pharmaceutical industry….
Drug discovery plays a key role in the pharma and biotech industries. Discovering unmet needs, pinpointing the target, identifying the…
The pharmaceutical industry spends billions on R&D each year. Clinical trials require tremendous amounts of effort, from identifying sites and…
Training algorithms to identify and extract Life Sciences-specific data The English dictionary is full of words and definitions that can be…
The early 1970s introduced the world to the idea of computer vision, a promising technology automating tasks that would otherwise…
Summary:AI could potentially speed drug discovery and save time in rejecting treatments that are unlikely to yield worthwhile resultsAI has…